United States Central Nervous System Biomarkers Market Report 2017

October 2017 | 101 pages | ID: UB4C9E33CD1EN
QYResearch

Abstracts

In this report, the United States Central Nervous System Biomarkers market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Central Nervous System Biomarkers in these regions, from 2012 to 2022 (forecast).

United States Central Nervous System Biomarkers market competition by top manufacturers/players, with Central Nervous System Biomarkers sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Thermo Fisher Scientific
• Merck & Co
• AbaStar MDx Inc
• Abiant, Inc
• Avacta Group Plc
• Diagenic Asa
• Banyan Biomarkers
• Avid Radiopharmaceuticals Inc

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Safety Biomarker
• Efficacy Biomarker
• Validation Biomarker
• Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospitals
• Clinics
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Central Nervous System Biomarkers Market Report 2017

1 CENTRAL NERVOUS SYSTEM BIOMARKERS OVERVIEW

1.1 Product Overview and Scope of Central Nervous System Biomarkers
1.2 Classification of Central Nervous System Biomarkers by Product Category
  1.2.1 United States Central Nervous System Biomarkers Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Central Nervous System Biomarkers Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Safety Biomarker
  1.2.4 Efficacy Biomarker
  1.2.5 Validation Biomarker
  1.2.6 Other
1.3 United States Central Nervous System Biomarkers Market by Application/End Users
  1.3.1 United States Central Nervous System Biomarkers Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospitals
  1.3.3 Clinics
  1.3.4 Other
1.4 United States Central Nervous System Biomarkers Market by Region
  1.4.1 United States Central Nervous System Biomarkers Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Central Nervous System Biomarkers Status and Prospect (2012-2022)
  1.4.3 Southwest Central Nervous System Biomarkers Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Central Nervous System Biomarkers Status and Prospect (2012-2022)
  1.4.5 New England Central Nervous System Biomarkers Status and Prospect (2012-2022)
  1.4.6 The South Central Nervous System Biomarkers Status and Prospect (2012-2022)
  1.4.7 The Midwest Central Nervous System Biomarkers Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Central Nervous System Biomarkers (2012-2022)
  1.5.1 United States Central Nervous System Biomarkers Sales and Growth Rate (2012-2022)
  1.5.2 United States Central Nervous System Biomarkers Revenue and Growth Rate (2012-2022)

2 UNITED STATES CENTRAL NERVOUS SYSTEM BIOMARKERS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Central Nervous System Biomarkers Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Central Nervous System Biomarkers Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Central Nervous System Biomarkers Average Price by Players/Suppliers (2012-2017)
2.4 United States Central Nervous System Biomarkers Market Competitive Situation and Trends
  2.4.1 United States Central Nervous System Biomarkers Market Concentration Rate
  2.4.2 United States Central Nervous System Biomarkers Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Central Nervous System Biomarkers Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES CENTRAL NERVOUS SYSTEM BIOMARKERS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Central Nervous System Biomarkers Sales and Market Share by Region (2012-2017)
3.2 United States Central Nervous System Biomarkers Revenue and Market Share by Region (2012-2017)
3.3 United States Central Nervous System Biomarkers Price by Region (2012-2017)

4 UNITED STATES CENTRAL NERVOUS SYSTEM BIOMARKERS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Central Nervous System Biomarkers Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Central Nervous System Biomarkers Revenue and Market Share by Type (2012-2017)
4.3 United States Central Nervous System Biomarkers Price by Type (2012-2017)
4.4 United States Central Nervous System Biomarkers Sales Growth Rate by Type (2012-2017)

5 UNITED STATES CENTRAL NERVOUS SYSTEM BIOMARKERS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Central Nervous System Biomarkers Sales and Market Share by Application (2012-2017)
5.2 United States Central Nervous System Biomarkers Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES CENTRAL NERVOUS SYSTEM BIOMARKERS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Thermo Fisher Scientific
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Central Nervous System Biomarkers Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Thermo Fisher Scientific Central Nervous System Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Merck & Co
  6.2.2 Central Nervous System Biomarkers Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Merck & Co Central Nervous System Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 AbaStar MDx Inc
  6.3.2 Central Nervous System Biomarkers Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 AbaStar MDx Inc Central Nervous System Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Abiant, Inc
  6.4.2 Central Nervous System Biomarkers Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Abiant, Inc Central Nervous System Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Avacta Group Plc
  6.5.2 Central Nervous System Biomarkers Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Avacta Group Plc Central Nervous System Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Diagenic Asa
  6.6.2 Central Nervous System Biomarkers Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Diagenic Asa Central Nervous System Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Banyan Biomarkers
  6.7.2 Central Nervous System Biomarkers Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Banyan Biomarkers Central Nervous System Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Avid Radiopharmaceuticals Inc
  6.8.2 Central Nervous System Biomarkers Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Avid Radiopharmaceuticals Inc Central Nervous System Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview

7 CENTRAL NERVOUS SYSTEM BIOMARKERS MANUFACTURING COST ANALYSIS

7.1 Central Nervous System Biomarkers Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Central Nervous System Biomarkers

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Central Nervous System Biomarkers Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Central Nervous System Biomarkers Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES CENTRAL NERVOUS SYSTEM BIOMARKERS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Central Nervous System Biomarkers Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Central Nervous System Biomarkers Sales Volume Forecast by Type (2017-2022)
11.3 United States Central Nervous System Biomarkers Sales Volume Forecast by Application (2017-2022)
11.4 United States Central Nervous System Biomarkers Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Central Nervous System Biomarkers
Figure United States Central Nervous System Biomarkers Market Size (K Units) by Type (2012-2022)
Figure United States Central Nervous System Biomarkers Sales Volume Market Share by Type (Product Category) in 2016
Figure Safety Biomarker Product Picture
Figure Efficacy Biomarker Product Picture
Figure Validation Biomarker Product Picture
Figure Other Product Picture
Figure United States Central Nervous System Biomarkers Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Central Nervous System Biomarkers by Application in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Central Nervous System Biomarkers Market Size (Million USD) by Region (2012-2022)
Figure The West Central Nervous System Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Central Nervous System Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Central Nervous System Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Central Nervous System Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Central Nervous System Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Central Nervous System Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Central Nervous System Biomarkers Sales (K Units) and Growth Rate (2012-2022)
Figure United States Central Nervous System Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Central Nervous System Biomarkers Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Central Nervous System Biomarkers Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Central Nervous System Biomarkers Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Central Nervous System Biomarkers Sales Share by Players/Suppliers
Figure 2017 United States Central Nervous System Biomarkers Sales Share by Players/Suppliers
Figure United States Central Nervous System Biomarkers Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Central Nervous System Biomarkers Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Central Nervous System Biomarkers Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Central Nervous System Biomarkers Revenue Share by Players/Suppliers
Figure 2017 United States Central Nervous System Biomarkers Revenue Share by Players/Suppliers
Table United States Market Central Nervous System Biomarkers Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Central Nervous System Biomarkers Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Central Nervous System Biomarkers Market Share of Top 3 Players/Suppliers
Figure United States Central Nervous System Biomarkers Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Central Nervous System Biomarkers Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Central Nervous System Biomarkers Product Category
Table United States Central Nervous System Biomarkers Sales (K Units) by Region (2012-2017)
Table United States Central Nervous System Biomarkers Sales Share by Region (2012-2017)
Figure United States Central Nervous System Biomarkers Sales Share by Region (2012-2017)
Figure United States Central Nervous System Biomarkers Sales Market Share by Region in 2016
Table United States Central Nervous System Biomarkers Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Central Nervous System Biomarkers Revenue Share by Region (2012-2017)
Figure United States Central Nervous System Biomarkers Revenue Market Share by Region (2012-2017)
Figure United States Central Nervous System Biomarkers Revenue Market Share by Region in 2016
Table United States Central Nervous System Biomarkers Price (USD/Unit) by Region (2012-2017)
Table United States Central Nervous System Biomarkers Sales (K Units) by Type (2012-2017)
Table United States Central Nervous System Biomarkers Sales Share by Type (2012-2017)
Figure United States Central Nervous System Biomarkers Sales Share by Type (2012-2017)
Figure United States Central Nervous System Biomarkers Sales Market Share by Type in 2016
Table United States Central Nervous System Biomarkers Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Central Nervous System Biomarkers Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Central Nervous System Biomarkers by Type (2012-2017)
Figure Revenue Market Share of Central Nervous System Biomarkers by Type in 2016
Table United States Central Nervous System Biomarkers Price (USD/Unit) by Types (2012-2017)
Figure United States Central Nervous System Biomarkers Sales Growth Rate by Type (2012-2017)
Table United States Central Nervous System Biomarkers Sales (K Units) by Application (2012-2017)
Table United States Central Nervous System Biomarkers Sales Market Share by Application (2012-2017)
Figure United States Central Nervous System Biomarkers Sales Market Share by Application (2012-2017)
Figure United States Central Nervous System Biomarkers Sales Market Share by Application in 2016
Table United States Central Nervous System Biomarkers Sales Growth Rate by Application (2012-2017)
Figure United States Central Nervous System Biomarkers Sales Growth Rate by Application (2012-2017)
Table Thermo Fisher Scientific Basic Information List
Table Thermo Fisher Scientific Central Nervous System Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Thermo Fisher Scientific Central Nervous System Biomarkers Sales Growth Rate (2012-2017)
Figure Thermo Fisher Scientific Central Nervous System Biomarkers Sales Market Share in United States (2012-2017)
Figure Thermo Fisher Scientific Central Nervous System Biomarkers Revenue Market Share in United States (2012-2017)
Table Merck & Co Basic Information List
Table Merck & Co Central Nervous System Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck & Co Central Nervous System Biomarkers Sales Growth Rate (2012-2017)
Figure Merck & Co Central Nervous System Biomarkers Sales Market Share in United States (2012-2017)
Figure Merck & Co Central Nervous System Biomarkers Revenue Market Share in United States (2012-2017)
Table AbaStar MDx Inc Basic Information List
Table AbaStar MDx Inc Central Nervous System Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AbaStar MDx Inc Central Nervous System Biomarkers Sales Growth Rate (2012-2017)
Figure AbaStar MDx Inc Central Nervous System Biomarkers Sales Market Share in United States (2012-2017)
Figure AbaStar MDx Inc Central Nervous System Biomarkers Revenue Market Share in United States (2012-2017)
Table Abiant, Inc Basic Information List
Table Abiant, Inc Central Nervous System Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abiant, Inc Central Nervous System Biomarkers Sales Growth Rate (2012-2017)
Figure Abiant, Inc Central Nervous System Biomarkers Sales Market Share in United States (2012-2017)
Figure Abiant, Inc Central Nervous System Biomarkers Revenue Market Share in United States (2012-2017)
Table Avacta Group Plc Basic Information List
Table Avacta Group Plc Central Nervous System Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Avacta Group Plc Central Nervous System Biomarkers Sales Growth Rate (2012-2017)
Figure Avacta Group Plc Central Nervous System Biomarkers Sales Market Share in United States (2012-2017)
Figure Avacta Group Plc Central Nervous System Biomarkers Revenue Market Share in United States (2012-2017)
Table Diagenic Asa Basic Information List
Table Diagenic Asa Central Nervous System Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Diagenic Asa Central Nervous System Biomarkers Sales Growth Rate (2012-2017)
Figure Diagenic Asa Central Nervous System Biomarkers Sales Market Share in United States (2012-2017)
Figure Diagenic Asa Central Nervous System Biomarkers Revenue Market Share in United States (2012-2017)
Table Banyan Biomarkers Basic Information List
Table Banyan Biomarkers Central Nervous System Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Banyan Biomarkers Central Nervous System Biomarkers Sales Growth Rate (2012-2017)
Figure Banyan Biomarkers Central Nervous System Biomarkers Sales Market Share in United States (2012-2017)
Figure Banyan Biomarkers Central Nervous System Biomarkers Revenue Market Share in United States (2012-2017)
Table Avid Radiopharmaceuticals Inc Basic Information List
Table Avid Radiopharmaceuticals Inc Central Nervous System Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Avid Radiopharmaceuticals Inc Central Nervous System Biomarkers Sales Growth Rate (2012-2017)
Figure Avid Radiopharmaceuticals Inc Central Nervous System Biomarkers Sales Market Share in United States (2012-2017)
Figure Avid Radiopharmaceuticals Inc Central Nervous System Biomarkers Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Central Nervous System Biomarkers
Figure Manufacturing Process Analysis of Central Nervous System Biomarkers
Figure Central Nervous System Biomarkers Industrial Chain Analysis
Table Raw Materials Sources of Central Nervous System Biomarkers Major Players/Suppliers in 2016
Table Major Buyers of Central Nervous System Biomarkers
Table Distributors/Traders List
Figure United States Central Nervous System Biomarkers Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Central Nervous System Biomarkers Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Central Nervous System Biomarkers Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Central Nervous System Biomarkers Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Central Nervous System Biomarkers Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Central Nervous System Biomarkers Sales Volume (K Units) Forecast by Type in 2022
Table United States Central Nervous System Biomarkers Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Central Nervous System Biomarkers Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Central Nervous System Biomarkers Sales Volume (K Units) Forecast by Application in 2022
Table United States Central Nervous System Biomarkers Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Central Nervous System Biomarkers Sales Volume Share Forecast by Region (2017-2022)
Figure United States Central Nervous System Biomarkers Sales Volume Share Forecast by Region (2017-2022)
Figure United States Central Nervous System Biomarkers Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources